• About Us
    • About Neurocrine
    • Leadership Team
      • Management Team
      • Board of Directors
    • Culture & Values
    • News & Events
    • Webcasts & Presentations
    • Contact Us
  • Patients & Families
    • Overview
    • Tardive Dyskinesia
    • Parkinson’s Disease
    • Congenital Adrenal Hyperplasia
    • Endometriosis
    • Uterine Fibroids
    • Polycystic Ovary Syndrome
  • Products
  • Pipeline
    • OVERVIEW
    • Parkinson’s Disease
      • Opicapone
        • Clinical Trials
      • VY-AADC
        • Clinical Trials
    • Congenital Adrenal Hyperplasia
      • NBI-74788
        • Clinical Trials
    • Women’s Health
      • Endometriosis
      • Uterine Fibroids
        • Clinical Trials
      • Polycystic Ovary Syndrome
    • Additional Pipeline Programs
  • Careers
    • Overview
    • Culture and Values
    • Benefits
    • Recruitment Agencies
  • Investors
    • Press Releases
    • Stock Quote
    • SEC Filings
    • Shareholder Contacts
    • Partners/Collaborators
    • Annual Meeting
    • Online Annual Reports
    • Ownership
    • Email Alerts
    • Corporate Governance
    • Webcasts & Presentations
  • Contact Us